Cysteinyl Leukotrienes and Their Receptors; Emerging Concepts.
10.4168/aair.2014.6.4.288
- Author:
Yoshihide KANAOKA
1
;
Joshua A BOYCE
Author Information
1. Jeff and Penny Vinik Center for Allergic Disease Research, Boston, MA, United States. ykanaoka@rics.bwh.harvard.edu
- Publication Type:Review
- Keywords:
Leukotrienes;
5-lipoxygenase;
asthma;
AERD
- MeSH:
Adaptive Immunity;
Arachidonate 5-Lipoxygenase;
Arachidonic Acid;
Asthma;
Clone Cells;
Cloning, Organism;
Humans;
Inflammation Mediators;
Leukotrienes*
- From:Allergy, Asthma & Immunology Research
2014;6(4):288-295
- CountryRepublic of Korea
- Language:English
-
Abstract:
Cysteinyl leukotrienes (cys-LTs) are potent mediators of inflammation derived from arachidonic acid through the 5-lipoxygenase/leukotriene C4 synthase pathway. The derivation of their chemical structures and identification of their pharmacologic properties predated the cloning of their classical receptors and the development of drugs that modify their synthesis and actions. Recent studies have revealed unanticipated insights into the regulation of cys-LT synthesis, the function of the cys-LTs in innate and adaptive immunity and human disease, and the identification of a new receptor for the cys-LTs. This review highlights these studies and summarizes their potential pathobiologic and therapeutic implications.
